# OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

> **NCT06377579** · — · RECRUITING · sponsor: **French Innovative Leukemia Organisation** · enrollment: 250 (estimated)

## Conditions studied

- AML, Adult

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06377579
- **Lead sponsor:** French Innovative Leukemia Organisation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-31
- **Primary completion:** 2025-08-30
- **Final completion:** 2026-06-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06377579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06377579, "OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06377579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*